Technical Analysis for JNJ - Johnson & Johnson
|Grade||Last Price||% Change||Price Change|
JNJ closed down 0.27 percent on Friday, September 22, 2017, on 82 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average.
Trend Table & Recent Alerts
|Weak or Absent||Up||Down||Down|
|See historical JNJ trend table...|
|Date||Alert Name||Type||% Chg|
|Sep 22||50 DMA Resistance||Bearish||0.00%|
|Sep 22||NR7||Range Contraction||0.00%|
|Sep 22||MACD Bearish Signal Line Cross||Bearish||0.00%|
|Sep 21||Fell Below 50 DMA||Bearish||-0.27%|
|Sep 20||Stochastic Sell Signal||Bearish||-1.37%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers products used in the baby care, skin care, oral care, wound care, and women's health fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON'S, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, DABAO, VENDÔME, LISTERINE, REMBRANDT, REACH, BAND-AID, NEOSPORIN, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products directly, as well as through surgical supply and other distributors to wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Is JNJ a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more JNJ news...
|52 Week High||136.2135|
|52 Week Low||107.2027|
|200-Day Moving Average||124.1146|
|50-Day Moving Average||132.3267|
|20-Day Moving Average||132.3875|
|10-Day Moving Average||133.391|
|Average True Range||1.6959|
|Chandelier Exit (Long, 3 ATRs)||130.7023|
|Chandelier Exit (Short, 3 ATRs)||134.8077|
|Upper Bollinger Band||135.3275|
|Lower Bollinger Band||129.4475|
|Percent B (%b)||0.33|
|MACD Signal Line||0.3365|